Investors

OpSens’ Versatile Technology Fulfills Needs in Key Markets

 

OpSens is always looking to innovate and find solutions to challenges and unmet needs in various markets.

Powered by FidelaTM, its 2nd generation fiber optic sensor, OpSens designed its flagship product, the OptoWire, a guidewire to assess, diagnose and treat coronary blockages by physiological measurement with confidence.

OpSens also capitalizes on its expertise developed in coronary physiology to extend its activities to the fast-growing sector of structural cardiology. OpSens will innovate with the first pressure guidewire to confirm positioning of valves in the treatment of aortic stenosis. This strategic product will help optimize the TAVR procedure.

OpSens’ optical technology can be adapted and integrated into various applications, allowing the company to partner in projects within several markets.

OpSens – Analyst Coverage

OpSens is currently covered by

Firm: RBC
Analyst: Doug Miehm

Firm: Ladenburg Thalmann
Analyst: Jeffrey S. Cohen

Firm: Paradigm Capital
Analyst:  Corey Hammill

Firm: M Partners
Analyst: Paul Piotrowski

The above list is provided for information purposes only. Opinions, estimates and/or forecasts regarding OpSens’ performance made by this or these analysts is their(s) alone and does not necessarily reflect opinions, forecasts or predictions of OpSens’ and/or its management.

Contact

Louis Laflamme
President & CEO

750 Boulevard du Parc Technologique.
Quebec, QC, Canada  G1P 4S3
Tel.: 418.781.0333
[email protected]

Auditor

Deloitte, s.e.n.c.r.l.
925 Grande-Allée Street West
Suite 400
Quebec, QC, Canada G1S 4Z4
Tel.: 418.624.3333

Transfer Agent & Registrar

Canadian Stock Transfer Company Inc. (CST)
320 Bay Street
B1 Level
Toronto, ON, Canada M5H 4A6
Tel.: 1.800.387.0825

* Links to third party sites are for informational purposes only. OpSens Inc. have not prepared, reviewed or updated any content on third party sites and assume no responsibility for the information posted on them.